Adjuvant Axitinib Treatment of Renal Cancer: A Randomized Double-blind Phase 3 Study of Adjuvant Axitinib vs. Placebo in Subjects at High Risk of Recurrent RCC
收藏DataCite Commons2025-06-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006826/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to determine if adjuvant therapy with axitinib will prevent or
delay the recurrence of renal cell cancer after surgery to remove the primary tumor in high
risk patients.
提供机构：
Vivli
创建时间：
2021-04-02
